BIOCONNSEBiocon Limited· PharmaceuticalsHighNeutral
Announced Mon, 12 Jan · 16:50 IST

Biocon Limited has informed the Exchange about Qualified Institutions Placement - Issue Opening

Fund Raising View source PDF

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biocon Limited has opened its Qualified Institutions Placement (QIP) issue today, January 12, 2026, to raise funds by issuing equity shares of face value ₹5 each to institutional investors. The floor price for the issue has been fixed at ₹387.74 per share, as per the SEBI ICDR pricing formula. The company may offer a discount of up to 5% on this floor price, with the final issue price to be determined in consultation with the book running lead managers. The QIP was approved by the Board on December 6, 2025, and by shareholders at the EGM held on December 31, 2025. The trading window for dealing in Biocon shares remains closed until further notice.

Likely market impact

This QIP will lead to dilution of existing shareholders but will bring fresh equity capital to support the company's growth plans. Short-term stock price may face pressure depending on the final issue price relative to the current market price and how the raised funds are deployed.